The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study

Chezi Ganzel*, Barbara Silverman, Daniel Chemtob, Assaf Ben Shoham, Yonit Wiener-Well

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Patients with cancer are at high risk for tuberculosis (TB). This study combined the Israeli databases of cancer and TB and examined the development of TB among all newly diagnosed cancer cases from 1993 to 2013. Patients were classified into groups according to their different malignancies. Among 495,335 cancer patients, 335 developed TB following cancer diagnosis. The cumulative incidence of TB following cancer diagnosis was highest among MDS/MPN (148.8/100,000 patients) and lymphoma (154.1/100,000 patients) (p =.023). The HR of TB following cancer among hematologic patients was 2.51 (p <.001), relative to patients with in situ carcinomas/skin cancer and highest among MDS/MPN and lymphoma patients (2.74, p =.012 and 2.70, p <.001, respectively). Among lymphoma patients, a significant increased HR was found only among NHL patients (2.72, p <.001). The limitations include lack of information regarding risk factors for TB and of anti-cancer treatments. In conclusion, these data may encourage a heightened awareness for TB among patients with a background of lymphoma and MDS/MPN.

Original languageEnglish
Pages (from-to)720-725
Number of pages6
JournalLeukemia and Lymphoma
Volume60
Issue number3
DOIs
StatePublished - 23 Feb 2019
Externally publishedYes

Keywords

  • MDS
  • MPN
  • Tuberculosis
  • cancer
  • lymphoma

Fingerprint

Dive into the research topics of 'The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study'. Together they form a unique fingerprint.

Cite this